| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,120 | 3,280 | 21.11. |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.11. | Kingfisher Metals Corp.: Kingfisher Outlines Six New Drill-Ready Porphyry Cu-Au Drill Targets at HWY 37 Project in the Golden Triangle, BC | VANCOUVER, BC / ACCESSWIRE / November 12, 2024 / Kingfisher Metals Corp. (TSXV:KFR)(FSE:970)(OTCQB:KGFMF) ("Kingfisher" or the "Company") is pleased to report new drill targets generated from the 2024... ► Artikel lesen | |
| 11.09. | Kingfisher Metals Corp (2): Kingfisher completes mapping, sampling, IP at HWY, LGM | ||
| 10.09. | Kingfisher Metals Corp.: Kingfisher Provides 2024 Exploration Update | VANCOUVER, BC / ACCESSWIRE / September 10, 2024 / Kingfisher Metals Corp. (TSXV:KFR)(FSE:970)(OTCQB:KGFMF) ("Kingfisher" or the "Company") is pleased to report the completion of its program of mapping... ► Artikel lesen | |
| 09.08. | Kingfisher Metals Corp (2): Kingfisher Metals agreement for LGM property | ||
| 10.07. | Kingfisher Metals completes acquisition of LGM project |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | PALISADE BIO, INC. - S-1/A, General form for registration of securities | ||
| Do | Palisade Bio, Inc.: Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn's Disease and Ulcerative Colitis (UC) | ||
| 14.11. | Palisade Bio, Inc.: Palisade Bio CMO Mitch Jones, MD, PhD, to Present at 8th Annual Antifibrotic Drug Development (AFDD) Summit | ||
| 12.11. | Palisade Bio, Inc.: Palisade Bio Reports Third Quarter 2024 Financial Results and Outlines Key Accomplishments and Next Steps to Advance Lead Program PALI-2108 | Commenced enrollment and dosing in Phase 1 clinical study of PALI-2108 for the treatment of moderate-to-severe Ulcerative Colitis (UC) Carlsbad, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Palisade Bio... ► Artikel lesen | |
| 07.11. | Palisade Bio startet Phase-1-Studie für neues Colitis-ulcerosa-Medikament |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.10. | Robex Resources Inc.: Kiniero auf dem Weg zu seinem ersten Gold im 4. Quartal 2025 | Höhepunkte:
Die erste Goldgewinnung ist für das 4. Quartal 2025 geplant, die wichtigsten Vorlaufprodukte sind beschafftErnennung des Projektentwicklungsteams unter der Leitung von Chief Development... ► Artikel lesen | |
| 09.10. | Robex Resources Inc (2): Robex appoints project development team for Kiniero | ||
| 08.10. | Robex Resources on pace for first gold in Q4 2025 at Kiniero | ||
| 08.10. | Robex Resources Inc.: Kiniero on Track for First Gold in Q4 2025 | Highlights:
First gold pour is on track for Q4 2025, key long lead items procuredProject Development team appointed, led by Chief Development Officer Dimitrios FelekisEngineering for doubling plant... ► Artikel lesen | |
| 19.09. | Robex's 3.4 Million Oz Gold Resource Project |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| KINGFISHER METALS CORP | 0,096 | +9,77 % |
| PALISADE BIO INC | 3,200 | 0,00 % |
| ROBEX RESOURCES INC | 1,670 | -1,76 % |
